Literature DB >> 6276390

A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.

S Cohen, H Ushiro, C Stoscheck, M Chinkers.   

Abstract

A method is presented for the preparation of a "native" epidermal growth factor (EGF) receptor-kinase complex of molecular weight 170,000 from A-431 cells. Although this receptor complex is capable of binding EGF, noncovalently, in quantities similar to the previously isolated 150,000 complex (Cohen, S., Carpenter, G., and King, L., Jr. (1980) J. Biol. Chem. 255, 4834-4842), the 170,000 preparation has 5 to 10 times the intrinsic kinase activity (autophosphorylation). However, the 170,000 kinase activity toward other proteins is lower than that of the 150,000 preparation. Both the 170,000 and 150,000 kinase activities are enhanced by EGF. The 170,000 and 150,000 proteins are also capable of forming covalent linkages to 125I-EGF, and each is precipitated by antisera directed against the 170,000 protein. We suggest the 150,000 protein is a proteolytic degradation product of the 170,000 protein. The EGF-enhanced kinase activity of the 170,000 preparation remains associated with the 125I-EGF-binding activity following EGF affinity chromatography, electrophoresis in nondenaturing gels, or immunoprecipitation with antisera directed against the sodium dodecyl sulfate (SDS) gel-purified 170,000 protein. These results indicate that the receptor, kinase, and substrate domains are linked, possibly covalently.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6276390

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  147 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

2.  FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Authors:  Alexandros Garouniatis; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

Review 3.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

4.  A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.

Authors:  R A Feldman; D R Lowy; W C Vass; T J Velu
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Temperature-dependent lateral and transverse distribution of the epidermal growth factor receptor in A431 plasma membranes.

Authors:  J R Azevedeo; D A Johnson
Journal:  J Membr Biol       Date:  1990-12       Impact factor: 1.843

6.  Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface.

Authors:  Aiwen Dong; Dariusz Wodziak; Anson W Lowe
Journal:  J Biol Chem       Date:  2015-02-09       Impact factor: 5.157

7.  N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy.

Authors:  Jennifer A Crozier; Pooja P Advani; Betsy LaPlant; Timothy Hobday; Anthony J Jaslowski; Alvaro Moreno-Aspitia; Edith A Perez
Journal:  Clin Breast Cancer       Date:  2015-08-19       Impact factor: 3.225

8.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

9.  Membrane Protein Dimerization in Cell-Derived Lipid Membranes Measured by FRET with MC Simulations.

Authors:  Jan Škerle; Jana Humpolíčková; Nicholas Johnson; Petra Rampírová; Edita Poláchová; Monika Fliegl; Jan Dohnálek; Anna Suchánková; David Jakubec; Kvido Strisovsky
Journal:  Biophys J       Date:  2020-03-29       Impact factor: 4.033

10.  In vitro enzymatic characterization of near full length EGFR in activated and inhibited states.

Authors:  Chen Qiu; Mary K Tarrant; Tatiana Boronina; Patti A Longo; Jennifer M Kavran; Robert N Cole; Philip A Cole; Daniel J Leahy
Journal:  Biochemistry       Date:  2009-07-21       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.